Blavatnik Family Women’s Health Research Institute

Search results

• Insulin resistance contributes to racial disparities in breast cancer prognosis in US women

  Nina Bickell

  12/05/20

  1 item of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast Cancer...

  Nina Bickell & Derek LeRoith

  12/05/20

  6 items of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast...

  Nina Bickell & Derek LeRoith

  12/05/20

  1 item of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal.

  Nina Bickell & Derek LeRoith

  12/05/20

  1 item of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal

  Derek LeRoith & Nina Bickell

  12/05/20

  1 item of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal

  Derek LeRoith & Nina Bickell

  12/05/20

  1 item of Media coverage

  Press/Media

• Does Insulin Resistance Worsen Breast Cancer Prognosis in Black Women?

  Nina Bickell & Emily Gallagher

  12/05/20

  1 item of Media coverage

  Press/Media

• Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal

  Derek LeRoith & Nina Bickell

  12/05/20

  1 item of Media coverage

  Press/Media

• MESOBLAST LIMITED : - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  7/05/20

  2 items of Media coverage

  Press/Media

• Mesoblast Limited: FIRST PATIENTS DOSED IN PHASE 2/3 RANDOMIZED CONTROLLED TRIAL OF MESOBLAST’S REMESTEMCEL-L FOR COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  7/05/20

  1 item of Media coverage

  Press/Media

• First patients dosed in Mesoblast COVID-19 trial

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  7/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome Australian Stock Exchange:MSB.AX

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  6/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  6/05/20

  1 item of Media coverage

  Press/Media

• MESOBLAST : First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  6/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  5/05/20 → 6/05/20

  22 items of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Alan Moskowitz, Emilia Bagiella & Annetine Gelijns

  6/05/20

  1 item of Media coverage

  Press/Media

• Neighborhood racial and economic polarization and severe maternal morbidity

  Teresa Janevic

  4/05/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns

  10/04/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Alan Moskowitz, John Levine, Emilia Bagiella, Keren Osman & Annetine Gelijns

  10/04/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns

  10/04/20

  2 items of Media coverage

  Press/Media

• OTTY Honoree 2020 Dr. Carol Horowitz: Healing from Within; How Dr. Carol Horowitz is breaking down barriers to help more patients — and doctors — thrive

  Carol Horowitz

  2/03/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Helps Liberia Build Its Sole Pathology Lab

  Ann Marie Beddoe

  25/02/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Helps Liberia Build Its Sole Pathology Lab

  Ann Marie Beddoe

  25/02/20

  1 item of Media coverage

  Press/Media

• In the Community:

  Emma Benn

  24/02/20

  1 item of Media coverage

  Press/Media

• In the Community: BYC Blue wins Aston A.A. fourth-grade tournament

  Emma Benn

  24/02/20

  1 item of Media coverage

  Press/Media